iBio, Inc. (IBIO)
1.125
+0.02
(+1.35%)
USD |
NASDAQ |
Oct 02, 16:00
1.09
-0.04
(-3.11%)
After-Hours: 20:00
iBio Total Liabilities (Quarterly) : 13.40M for June 30, 2026
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 13.40M |
| March 31, 2026 | 8.297M |
| December 31, 2025 | 7.833M |
| September 30, 2025 | 8.116M |
| June 30, 2025 | 8.305M |
| March 31, 2025 | 7.722M |
| December 31, 2024 | 7.802M |
| September 30, 2024 | 6.763M |
| June 30, 2024 | 7.41M |
| March 31, 2024 | 25.29M |
| December 31, 2023 | 24.82M |
| September 30, 2023 | 24.47M |
| June 30, 2023 | 25.83M |
| March 31, 2023 | 27.00M |
| December 31, 2022 | 32.98M |
| September 30, 2022 | 36.20M |
| June 30, 2022 | 35.92M |
| March 31, 2022 | 35.99M |
| December 31, 2021 | 35.85M |
| September 30, 2021 | 43.21M |
| June 30, 2021 | 38.40M |
| March 31, 2021 | 37.87M |
| December 31, 2020 | 38.08M |
| September 30, 2020 | 37.21M |
| June 30, 2020 | 37.58M |
| Date | Value |
|---|---|
| March 31, 2020 | 38.26M |
| December 31, 2019 | 36.90M |
| September 30, 2019 | 37.10M |
| June 30, 2019 | 28.13M |
| March 31, 2019 | 28.77M |
| December 31, 2018 | 29.22M |
| September 30, 2018 | 29.87M |
| June 30, 2018 | 26.92M |
| March 31, 2018 | 26.88M |
| December 31, 2017 | 27.03M |
| September 30, 2017 | 27.14M |
| June 30, 2017 | 27.10M |
| March 31, 2017 | 27.75M |
| December 31, 2016 | 27.04M |
| September 30, 2016 | 27.39M |
| June 30, 2016 | 27.56M |
| March 31, 2016 | 27.75M |
| December 31, 2015 | 1.538M |
| September 30, 2015 | 1.565M |
| June 30, 2015 | 1.263M |
| March 31, 2015 | 1.254M |
| December 31, 2014 | 1.475M |
| September 30, 2014 | 1.218M |
| June 30, 2014 | 0.395M |
| March 31, 2014 | 1.213M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| ACADIA Pharmaceuticals, Inc. | 436.29M |
| Alnylam Pharmaceuticals, Inc. | 4.205B |
| Savara, Inc. | 48.48M |
| Vericel Corp. | 132.82M |
| Biogen, Inc. | 13.24B |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 99.11M |
| Shareholders Equity (Quarterly) | 85.71M |
| Debt to Equity Ratio | 0.0256 |
| Current Ratio | 7.852 |
| Net Debt Paydown Yield | 0.34% |